David Aguilar, MD

David Aguilar, MD, is an associate professor in the Department of Internal Medicine, Division of Cardiology at McGovern Medical School He has a dual appointment in the Department of Epidemiology, Human Genetics, and Environmental Sciences at UTHealth’s School of Public Health.

Show full bio

Dr. Aguilar has advanced training in non-invasive imaging, including echocardiography and nuclear cardiology. He is a Fellow of the American Heart Association. He has been an associate editor and on the editorial board of multiple journals. He has been the principal investigator and co-investigator in multiple grants from the National Institutes of Health and has been actively involved in clinical trials testing new treatment strategies in cardiovascular disease.

His research interests have focused predominantly on the impact of cardiometabolic disease (including type 2 diabetes mellitus) on health outcomes. Dr. Aguilar has authored and co-authored more than 70 publications and book chapters.

As a native Houstonian, Dr. Aguilar is active in the community, previously serving on the Board of Directors for the American Heart Association in Houston. He is also active in teaching endeavors, both locally and nationally.

See Publications

Texas Heart Institute Positions

Interests

  • General cardiology
  • Echocardiography
  • Cardiometabolic disease

Education

  • Medical School:

    Baylor College of Medicine

  • Residency:

    Harvard Medical School

  • Fellowships:

    Harvard Medical School

Certifications

  • American Board of Internal Medicine

Honors, Awards and Memberships

Publications

4862227 86PR9WQF 1 alternatives-to-animal-experimentation 10 date desc Aguilar 21380 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%228XUHDZNP%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Diaz%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDiaz%2C%20P.%2C%20Coughlin%2C%20W.%2C%20Lam%2C%20W.%20et%20al.%20%282022%29.%20Describing%20characteristics%20of%20adults%20with%20and%20without%20congenital%20heart%20defects%20hospitalized%20with%20COVID-19.%20%26lt%3Bi%26gt%3BBirth%20Defects%20Res%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fbdr2.2052%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fbdr2.2052%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Describing%20characteristics%20of%20adults%20with%20and%20without%20congenital%20heart%20defects%20hospitalized%20with%20COVID-19%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Perla%22%2C%22lastName%22%3A%22Diaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Will%22%2C%22lastName%22%3A%22Coughlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wilson%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Ermis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecilia%20M.%22%2C%22lastName%22%3A%22Ganduglia%20Cazaban%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20J.%22%2C%22lastName%22%3A%22Agopian%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20We%20sought%20to%20describe%20patient%20characteristics%20in%20adults%20with%20and%20without%20congenital%20heart%20defects%20%28CHDs%29%20during%20hospitalization%20for%20COVID-19.%5CnMETHODS%3A%20We%20analyzed%20data%20collected%20by%20Optum%5Cu00ae%2C%20a%20nationally%20representative%20database%20of%20electronic%20medical%20records%2C%20for%20369%20adults%20with%20CHDs%20and%2041%2C578%20without%20CHDs%20hospitalized%20for%20COVID-19%20between%20January%201%2C%202020%2C%20and%20December%2010%2C%202020.%20We%20used%20Poisson%20regression%20to%20describe%20and%20compare%20epidemiologic%20characteristics%2C%20heart-related%20conditions%2C%20and%20severe%20outcomes%20between%20these%20two%20groups.%5CnRESULTS%3A%20The%20distributions%20of%20many%20epidemiologic%20characteristics%20were%20similar%20between%20the%20two%20groups%2C%20but%20patients%20with%20CHDs%20were%20significantly%20more%20likely%20to%20be%20current%20or%20former%20smokers%20compared%20to%20patients%20without%20CHDs%20%28risk%20ratio%20%5BRR%5D%3A%201.5%2C%2095%25%20confidence%20interval%20%5BCI%5D%3A%201.2%2C%201.8%29.%20Patients%20with%20CHDs%20were%20also%20significantly%20more%20likely%20to%20have%20heart%20failure%2C%20stroke%2C%20acute%20arrhythmia%2C%20myocardial%20injury%2C%20acute%20pulmonary%20hypertension%2C%20venous%20thromboembolism%2C%20and%20obesity%20documented%20at%20the%20time%20of%20the%20COVID-19%20hospitalization%20%28RR%20range%3A%201.5-4.7%29%20but%20not%20respiratory%20failure.%20Patients%20with%20CHDs%20%287%5Cu2009days%29%20had%20a%20significantly%20longer%20median%20length%20of%20stay%20than%20those%20without%20CHDs%20%285%5Cu2009days%3B%20p%5Cu2009%26lt%3B%5Cu2009.001%29%20and%20were%20significantly%20more%20likely%20to%20have%20an%20intensive%20care%20unit%20%28ICU%29%20admission%20%28RR%3A%201.6%2C%2095%20CI%3A%201.2-1.9%29.%5CnCONCLUSIONS%3A%20Our%20description%20of%20patients%20among%20a%20large%20population%20improves%20our%20understanding%20of%20the%20clinical%20course%20of%20COVID-19%20among%20adults%20with%20CHDs.%20Adults%20with%20CHD%20appear%20to%20be%20at%20greater%20risk%20for%20more%20severe%20CHD%2C%20including%20greater%20risk%20of%20ICU%20admission%20and%20longer%20length%20of%20hospital%20stays.%22%2C%22date%22%3A%22June%2011%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fbdr2.2052%22%2C%22ISSN%22%3A%222472-1727%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%225P97GH9U%22%2C%2286PR9WQF%22%2C%22QNJADXH4%22%2C%22ZSY78DJL%22%5D%2C%22dateModified%22%3A%222022-07-06T19%3A08%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22GEXTNU9X%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Weiss%20et%20al.%22%2C%22parsedDate%22%3A%222022-03-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWeiss%2C%20M.%20C.%2C%20Shih%2C%20Y.-H.%2C%20Bryan%2C%20M.%20S.%20et%20al.%20%282022%29.%20Relationships%20between%20urinary%20metals%20and%20diabetes%20traits%20among%20Mexican%20Americans%20in%20Starr%20County%2C%20Texas%2C%20USA.%20%26lt%3Bi%26gt%3BBiol%20Trace%20Elem%20Res%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12011-022-03165-y%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12011-022-03165-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Relationships%20between%20urinary%20metals%20and%20diabetes%20traits%20among%20Mexican%20Americans%20in%20Starr%20County%2C%20Texas%2C%20USA%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%20C.%22%2C%22lastName%22%3A%22Weiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-Hsuan%22%2C%22lastName%22%3A%22Shih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Molly%20Scannell%22%2C%22lastName%22%3A%22Bryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20P.%22%2C%22lastName%22%3A%22Jackson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Craig%20L.%22%2C%22lastName%22%3A%22Hanis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Argos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20M.%22%2C%22lastName%22%3A%22Sargis%22%7D%5D%2C%22abstractNote%22%3A%22Hispanics%5C%2FLatinos%20have%20higher%20rates%20of%20type%202%20diabetes%20%28T2D%29%2C%20and%20the%20origins%20of%20these%20disparities%20are%20poorly%20understood.%20Environmental%20endocrine-disrupting%20chemicals%20%28EDCs%29%2C%20including%20some%20metals%20and%20metalloids%2C%20are%20implicated%20as%20diabetes%20risk%20factors.%20Data%20indicate%20that%20Hispanics%5C%2FLatinos%20may%20be%20disproportionately%20exposed%20to%20EDCs%2C%20yet%20they%20remain%20understudied%20with%20respect%20to%20environmental%20exposures%20and%20diabetes.%20The%20objective%20of%20this%20study%20is%20to%20determine%20how%20metal%20exposures%20contribute%20to%20T2D%20progression%20by%20evaluating%20the%20associations%20between%208%20urinary%20metals%20and%20measures%20of%20glycemic%20status%20in%20414%20normoglycemic%20or%20prediabetic%20adults%20living%20in%20Starr%20County%2C%20Texas%2C%20a%20Hispanic%5C%2FLatino%20community%20with%20high%20rates%20of%20diabetes%20and%20diabetes-associated%20mortality.%20We%20used%20multivariable%20linear%20regression%20to%20quantify%20the%20differences%20in%20homeostatic%20model%20assessments%20for%20pancreatic%20%5Cu03b2-cell%20function%2C%20insulin%20resistance%2C%20and%20insulin%20sensitivity%20%28HOMA-%5Cu03b2%2C%20HOMA-IR%2C%20HOMA-S%2C%20respectively%29%2C%20plasma%20insulin%2C%20plasma%20glucose%2C%20and%20hemoglobin%20A1c%20%28HbA1c%29%20associated%20with%20increasing%20urinary%20metal%20concentrations.%20Quantile-based%20g-computation%20was%20utilized%20to%20assess%20mixture%20effects.%20After%20multivariable%20adjustment%2C%20urinary%20arsenic%20and%20molybdenum%20were%20associated%20with%20lower%20HOMA-%5Cu03b2%2C%20HOMA-IR%2C%20and%20plasma%20insulin%20levels%20and%20higher%20HOMA-S.%20Additionally%2C%20higher%20urinary%20copper%20levels%20were%20associated%20with%20a%20reduced%20HOMA-%5Cu03b2.%20Lastly%2C%20a%20higher%20concentration%20of%20the%208%20metal%20mixtures%20was%20associated%20with%20lower%20HOMA-%5Cu03b2%2C%20HOMA-IR%2C%20and%20plasma%20insulin%20levels%20as%20well%20as%20higher%20HOMA-S.%20Our%20data%20indicate%20that%20arsenic%2C%20molybdenum%2C%20copper%2C%20and%20this%20metal%20mixture%20are%20associated%20with%20alterations%20in%20measures%20of%20glucose%20homeostasis%20among%20non-diabetics%20in%20Starr%20County.%20This%20study%20is%20one%20of%20the%20first%20to%20comprehensively%20evaluate%20associations%20of%20urinary%20metals%20with%20glycemic%20measures%20in%20a%20high-risk%20Mexican%20American%20population.%22%2C%22date%22%3A%22Mar%2005%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12011-022-03165-y%22%2C%22ISSN%22%3A%221559-0720%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2286PR9WQF%22%2C%22LNSKD4V3%22%5D%2C%22dateModified%22%3A%222022-03-29T18%3A45%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22W38HRHPU%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kwak%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-12%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKwak%2C%20M.%20J.%2C%20Chang%2C%20M.%2C%20Chiadika%2C%20S.%20et%20al.%20%282022%29.%20Healthcare%20expenditure%20associated%20with%20polypharmacy%20in%20older%20adults%20with%20cardiovascular%20diseases.%20%26lt%3Bi%26gt%3BAm%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%2C%20S0002-9149%2822%2900030%26%23x2013%3B3.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2022.01.012%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2022.01.012%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Healthcare%20expenditure%20associated%20with%20polypharmacy%20in%20older%20adults%20with%20cardiovascular%20diseases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%20Ji%22%2C%22lastName%22%3A%22Kwak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mihyun%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simbo%22%2C%22lastName%22%3A%22Chiadika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elenir%22%2C%22lastName%22%3A%22Avritscher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashish%22%2C%22lastName%22%3A%22Deshmukh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parag%22%2C%22lastName%22%3A%22Goyal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dae%20Hyun%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajender%22%2C%22lastName%22%3A%22Aparasu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Holly%20M.%22%2C%22lastName%22%3A%22Holmes%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Feb%2012%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjcard.2022.01.012%22%2C%22ISSN%22%3A%221879-1913%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2286PR9WQF%22%2C%22WC4XX237%22%5D%2C%22dateModified%22%3A%222022-02-25T20%3A31%3A40Z%22%7D%7D%2C%7B%22key%22%3A%225GYGN3CX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hasbani%20et%20al.%22%2C%22parsedDate%22%3A%222022-01-31%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHasbani%2C%20N.%20R.%2C%20Ligthart%2C%20S.%2C%20Brown%2C%20M.%20R.%20et%20al.%20%282022%29.%20American%20Heart%20Association%26%23x2019%3Bs%20Life%26%23x2019%3Bs%20Simple%207%3A%20Lifestyle%20recommendations%2C%20polygenic%20risk%2C%20and%20lifetime%20risk%20of%20coronary%20heart%20disease.%20%26lt%3Bi%26gt%3BCirculation%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.121.053730%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCULATIONAHA.121.053730%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22American%20Heart%20Association%27s%20Life%27s%20Simple%207%3A%20Lifestyle%20recommendations%2C%20polygenic%20risk%2C%20and%20lifetime%20risk%20of%20coronary%20heart%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%20R.%22%2C%22lastName%22%3A%22Hasbani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Symen%22%2C%22lastName%22%3A%22Ligthart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20R.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20S.%22%2C%22lastName%22%3A%22Heath%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allison%22%2C%22lastName%22%3A%22Bebo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kellan%20E.%22%2C%22lastName%22%3A%22Ashley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Boerwinkle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alanna%20C.%22%2C%22lastName%22%3A%22Morrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20R.%22%2C%22lastName%22%3A%22Folsom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20S.%22%2C%22lastName%22%3A%22De%20Vries%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Understanding%20the%20effect%20of%20lifestyle%20and%20genetic%20risk%20on%20the%20lifetime%20risk%20of%20coronary%20heart%20disease%20%28CHD%29%20is%20important%20to%20improving%20public%20health%20initiatives.%20Our%20objective%20was%20to%20quantify%20remaining%20lifetime%20risk%20and%20years%20free%20of%20CHD%20according%20to%20polygenic%20risk%20and%20the%20American%20Heart%20Association%26%23039%3Bs%20Life%26%23039%3Bs%20Simple%207%20%28LS7%29%20guidelines%20in%20a%20population-based%20cohort%20study.%20Methods%3A%20Our%20analysis%20included%20data%20from%20participants%20of%20the%20ARIC%20%28Atherosclerosis%20Risk%20in%20Communities%29%20study%3A%208372%20White%20and%202314%20Black%20participants%3B%2045%20years%20of%20age%20and%20older%3B%20and%20free%20of%20CHD%20at%20baseline%20examination.%20A%20polygenic%20risk%20score%20%28PRS%29%20comprised%20more%20than%206%20million%20genetic%20variants%20was%20categorized%20into%20low%20%28%26lt%3B20th%20percentile%29%2C%20intermediate%2C%20and%20high%20%28%26gt%3B80th%20percentile%29.%20An%20overall%20LS7%20score%20was%20calculated%20at%20baseline%20and%20categorized%20into%20%26quot%3Bpoor%2C%26quot%3B%20%26quot%3Bintermediate%2C%26quot%3B%20and%20%26quot%3Bideal%26quot%3B%20cardiovascular%20health.%20Lifetime%20risk%20and%20CHD-free%20years%20were%20computed%20according%20to%20polygenic%20risk%20and%20LS7%20categories.%20Results%3A%20The%20overall%20remaining%20lifetime%20risk%20was%2027%25%2C%20ranging%20from%2016.6%25%20in%20individuals%20with%20an%20ideal%20LS7%20score%20to%2043.1%25%20for%20individuals%20with%20a%20poor%20LS7%20score.%20The%20association%20of%20PRS%20with%20lifetime%20risk%20differed%20according%20to%20ancestry.%20In%20White%20participants%2C%20remaining%20lifetime%20risk%20ranged%20from%2019.8%25%20to%2039.3%25%20according%20to%20increasing%20PRS%20categories.%20Individuals%20with%20a%20high%20PRS%20and%20poor%20LS7%20had%20a%20remaining%20lifetime%20risk%20of%2067.1%25%20and%2015.9%20fewer%20CHD-free%20years%20than%20did%20those%20with%20intermediate%20polygenic%20risk%20and%20LS7%20scores.%20In%20the%20high-PRS%20group%2C%20ideal%20LS7%20was%20associated%20with%2020.2%20more%20CHD-free%20years%20compared%20with%20poor%20LS7.%20In%20Black%20participants%2C%20remaining%20lifetime%20risk%20ranged%20from%2019.1%25%20to%2028.6%25%20according%20to%20increasing%20PRS%20category.%20Similar%20lifetime%20risk%20estimates%20were%20observed%20for%20individuals%20of%20poor%20LS7%20regardless%20of%20PRS%20category.%20In%20the%20high-PRS%20group%2C%20an%20ideal%20LS7%20score%20was%20associated%20with%20only%204.5%20more%20CHD-free%20years%20compared%20with%20a%20poor%20LS7%20score.%20Conclusions%3A%20Ideal%20adherence%20to%20LS7%20recommendations%20was%20associated%20with%20lower%20lifetime%20risk%20of%20CHD%20for%20all%20individuals%2C%20especially%20in%20those%20with%20high%20genetic%20susceptibility.%20In%20Black%20participants%2C%20adherence%20to%20LS7%20guidelines%20contributed%20to%20lifetime%20risk%20of%20CHD%20more%20so%20than%20current%20PRSs.%20Improved%20PRSs%20are%20needed%20to%20properly%20evaluate%20genetic%20susceptibility%20for%20CHD%20in%20diverse%20populations.%22%2C%22date%22%3A%22Jan%2031%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCULATIONAHA.121.053730%22%2C%22ISSN%22%3A%221524-4539%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VYVQ37MR%22%2C%2286PR9WQF%22%2C%22WC4XX237%22%5D%2C%22dateModified%22%3A%222022-02-25T20%3A24%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22VPB6MA6V%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Joseph%20et%20al.%22%2C%22parsedDate%22%3A%222022-01-10%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJoseph%2C%20J.%20J.%2C%20Deedwania%2C%20P.%2C%20Acharya%2C%20T.%20et%20al.%20%282022%29.%20Comprehensive%20management%20of%20cardiovascular%20risk%20factors%20for%20adults%20with%20type%202%20diabetes%3A%20A%20scientific%20statement%20from%20the%20American%20Heart%20Association.%20%26lt%3Bi%26gt%3BCirculation%26lt%3B%5C%2Fi%26gt%3B%2C%20CIR0000000000001040.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIR.0000000000001040%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIR.0000000000001040%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comprehensive%20management%20of%20cardiovascular%20risk%20factors%20for%20adults%20with%20type%202%20diabetes%3A%20A%20scientific%20statement%20from%20the%20American%20Heart%20Association%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20J.%22%2C%22lastName%22%3A%22Joseph%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prakash%22%2C%22lastName%22%3A%22Deedwania%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tushar%22%2C%22lastName%22%3A%22Acharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepak%20L.%22%2C%22lastName%22%3A%22Bhatt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deborah%20A.%22%2C%22lastName%22%3A%22Chyun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%20E.%22%2C%22lastName%22%3A%22Di%20Palo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherita%20H.%22%2C%22lastName%22%3A%22Golden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%20S.%22%2C%22lastName%22%3A%22Sperling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22American%20Heart%20Association%20Diabetes%20Committee%20of%20the%20Council%20on%20Lifestyle%20and%20Cardiometabolic%20Health%3B%20Council%20on%20Arteriosclerosis%2C%20Thrombosis%20and%20Vascular%20Biology%3B%20Council%20on%20Clinical%20Cardiology%3B%20and%20Council%20on%20Hypertension%22%7D%5D%2C%22abstractNote%22%3A%22Cardiovascular%20disease%20remains%20the%20leading%20cause%20of%20death%20in%20patients%20with%20diabetes.%20Cardiovascular%20disease%20in%20diabetes%20is%20multifactorial%2C%20and%20control%20of%20the%20cardiovascular%20risk%20factors%20leads%20to%20substantial%20reductions%20in%20cardiovascular%20events.%20The%202015%20American%20Heart%20Association%20and%20American%20Diabetes%20Association%20scientific%20statement%2C%20%26quot%3BUpdate%20on%20Prevention%20of%20Cardiovascular%20Disease%20in%20Adults%20With%20Type%202%20Diabetes%20Mellitus%20in%20Light%20of%20Recent%20Evidence%2C%26quot%3B%20highlighted%20the%20importance%20of%20modifying%20various%20risk%20factors%20responsible%20for%20cardiovascular%20disease%20in%20diabetes.%20At%20the%20time%2C%20there%20was%20limited%20evidence%20to%20suggest%20that%20glucose-lowering%20medications%20reduce%20the%20risk%20of%20cardiovascular%20events.%20At%20present%2C%20several%20large%20randomized%20controlled%20trials%20with%20newer%20antihyperglycemic%20agents%20have%20been%20completed%2C%20demonstrating%20cardiovascular%20safety%20and%20reduction%20in%20cardiovascular%20outcomes%2C%20including%20cardiovascular%20death%2C%20myocardial%20infarction%2C%20stroke%2C%20and%20heart%20failure.%20This%20AHA%20scientific%20statement%20update%20focuses%20on%20%281%29%20the%20evidence%20and%20clinical%20utility%20of%20newer%20antihyperglycemic%20agents%20in%20improving%20glycemic%20control%20and%20reducing%20cardiovascular%20events%20in%20diabetes%3B%20%282%29%20the%20impact%20of%20blood%20pressure%20control%20on%20cardiovascular%20events%20in%20diabetes%3B%20and%20%283%29%20the%20role%20of%20newer%20lipid-lowering%20therapies%20in%20comprehensive%20cardiovascular%20risk%20management%20in%20adults%20with%20diabetes.%20This%20scientific%20statement%20addresses%20the%20continued%20importance%20of%20lifestyle%20interventions%2C%20pharmacological%20therapy%2C%20and%20surgical%20interventions%20to%20curb%20the%20epidemic%20of%20obesity%20and%20metabolic%20syndrome%2C%20important%20precursors%20of%20prediabetes%2C%20diabetes%2C%20and%20comorbid%20cardiovascular%20disease.%20Last%2C%20this%20scientific%20statement%20explores%20the%20critical%20importance%20of%20the%20social%20determinants%20of%20health%20and%20health%20equity%20in%20the%20continuum%20of%20care%20in%20diabetes%20and%20cardiovascular%20disease.%22%2C%22date%22%3A%222022-01-10%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIR.0000000000001040%22%2C%22ISSN%22%3A%221524-4539%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2286PR9WQF%22%2C%22IEPEFS59%22%5D%2C%22dateModified%22%3A%222022-02-04T16%3A44%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22EGRARTRB%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brady%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrady%2C%20V.%2C%20Whisenant%2C%20M.%2C%20Wang%2C%20X.%20et%20al.%20%282022%29.%20Characterization%20of%20symptoms%20and%20symptom%20clusters%20for%20type%202%20diabetes%20using%20a%20large%20nationwide%20electronic%20health%20record%20database.%20%26lt%3Bi%26gt%3BDiabetes%20Spectr%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B35%26lt%3B%5C%2Fi%26gt%3B%2C%20159%26%23x2013%3B170.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2337%5C%2Fds21-0064%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2337%5C%2Fds21-0064%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characterization%20of%20symptoms%20and%20symptom%20clusters%20for%20type%202%20diabetes%20using%20a%20large%20nationwide%20electronic%20health%20record%20database%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veronica%22%2C%22lastName%22%3A%22Brady%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meagan%22%2C%22lastName%22%3A%22Whisenant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xueying%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vi%20K.%22%2C%22lastName%22%3A%22Ly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gen%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hulin%22%2C%22lastName%22%3A%22Wu%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20A%20variety%20of%20symptoms%20may%20be%20associated%20with%20type%202%20diabetes%20and%20its%20complications.%20Symptoms%20in%20chronic%20diseases%20may%20be%20described%20in%20terms%20of%20prevalence%2C%20severity%2C%20and%20trajectory%20and%20often%20co-occur%20in%20groups%2C%20known%20as%20symptom%20clusters%2C%20which%20may%20be%20representative%20of%20a%20common%20etiology.%20The%20purpose%20of%20this%20study%20was%20to%20characterize%20type%202%20diabetes-related%20symptoms%20using%20a%20large%20nationwide%20electronic%20health%20record%20%28EHR%29%20database.%5CnMETHODS%3A%20We%20acquired%20the%20Cerner%20Health%20Facts%2C%20a%20nationwide%20EHR%20database.%20The%20type%202%20diabetes%20cohort%20%28n%20%3D%201%2C136%2C301%20patients%29%20was%20identified%20using%20a%20rule-based%20phenotype%20method.%20A%20multistep%20procedure%20was%20then%20used%20to%20identify%20type%202%20diabetes-related%20symptoms%20based%20on%20International%20Classification%20of%20Diseases%2C%209th%20and%2010th%20revisions%2C%20diagnosis%20codes.%20Type%202%20diabetes-related%20symptoms%20and%20co-occurring%20symptom%20clusters%2C%20including%20their%20temporal%20patterns%2C%20were%20characterized%20based%20the%20longitudinal%20EHR%20data.%5CnRESULTS%3A%20Patients%20had%20a%20mean%20age%20of%2061.4%20years%2C%2051.2%25%20were%20female%2C%20and%2070.0%25%20were%20White.%20Among%201%2C136%2C301%20patients%2C%20there%20were%208%2C008%2C276%20occurrences%20of%2059%20symptoms.%20The%20most%20frequently%20reported%20symptoms%20included%20pain%2C%20heartburn%2C%20shortness%20of%20breath%2C%20fatigue%2C%20and%20swelling%2C%20which%20occurred%20in%2021-60%25%20of%20the%20patients.%20We%20also%20observed%20over-represented%20type%202%20diabetes%20symptoms%2C%20including%20difficulty%20speaking%2C%20feeling%20confused%2C%20trouble%20remembering%2C%20weakness%2C%20and%20drowsiness%5C%2Fsleepiness.%20Some%20of%20these%20are%20rare%20and%20difficult%20to%20detect%20by%20traditional%20patient-reported%20outcomes%20studies.%5CnCONCLUSION%3A%20To%20the%20best%20of%20our%20knowledge%2C%20this%20is%20the%20first%20study%20to%20use%20a%20nationwide%20EHR%20database%20to%20characterize%20type%202%20diabetes-related%20symptoms%20and%20their%20temporal%20patterns.%20Fifty-nine%20symptoms%2C%20including%20both%20over-represented%20and%20rare%20diabetes-related%20symptoms%2C%20were%20identified.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2337%5C%2Fds21-0064%22%2C%22ISSN%22%3A%221040-9165%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2286PR9WQF%22%2C%22JD5ZU4IS%22%5D%2C%22dateModified%22%3A%222023-03-13T20%3A12%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22Z49LYIYE%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jia%20et%20al.%22%2C%22parsedDate%22%3A%222021-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJia%2C%20X.%2C%20Sun%2C%20C.%2C%20Tanaka%2C%20H.%20et%20al.%20%282021%29.%20Association%20between%20circulating%20Galectin-3%20and%20arterial%20stiffness%20in%20older%20adults.%20%26lt%3Bi%26gt%3BVasa%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B50%26lt%3B%5C%2Fi%26gt%3B%2C%20439%26%23x2013%3B445.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1024%5C%2F0301-1526%5C%2Fa000968%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1024%5C%2F0301-1526%5C%2Fa000968%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20between%20circulating%20Galectin-3%20and%20arterial%20stiffness%20in%20older%20adults%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaoming%22%2C%22lastName%22%3A%22Jia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hirofumi%22%2C%22lastName%22%3A%22Tanaka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahmoud%22%2C%22lastName%22%3A%22Al%20Rifai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiadi%22%2C%22lastName%22%3A%22Ndumele%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Selvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salim%20S.%22%2C%22lastName%22%3A%22Virani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ron%20C.%22%2C%22lastName%22%3A%22Hoogeveen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerardo%22%2C%22lastName%22%3A%22Heiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christie%20M.%22%2C%22lastName%22%3A%22Ballantyne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Nambi%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Galectin-3%20%28gal-3%29%20is%20a%20%5Cu03b2-galactoside-binding%20lectin%20associated%20tissue%20fibrosis%20and%20inflammation.%20There%20is%20limited%20understanding%20of%20the%20relationship%20between%20gal-3%20and%20vascular%20health.%20Our%20aim%20was%20to%20assess%20the%20association%20between%20gal-3%20and%20arterial%20stiffness%20in%20older%20adults.%20Methods%3A%20We%20conducted%20a%20cross-sectional%20study%20of%204275%20participants%20%28mean%20age%20of%2075%20years%29%20from%20the%20Atherosclerosis%20Risk%20in%20Communities%20%28ARIC%29%20Study.%20Central%20arterial%20stiffness%20was%20measured%20by%20carotid-femoral%20pulse%20wave%20velocity%20%28cfPWV%29.%20We%20evaluated%20the%20association%20of%20gal-3%20with%20cfPWV%20using%20multivariable%20linear%20regression.%20Results%3A%20The%20median%20%28interquartile%20range%29%20gal-3%20concentration%20was%2016.5%20%2813.8%2C%2019.8%29%20ng%5C%2FmL%20and%20mean%20cfPWV%20was%201163%5Cu00b1303%20cm%5C%2Fs.%20Higher%20gal-3%20concentration%20was%20associated%20with%20greater%20central%20arterial%20stiffness%20after%20adjustment%20for%20age%2C%20sex%2C%20race-center%2C%20heart%20rate%2C%20systolic%20blood%20pressure%2C%20anti-hypertensive%20medication%20use%2C%20and%20current%20smoking%20status%20%28%5Cu03b2%3D36.4%20cm%5C%2Fs%20change%20in%20cfPWV%20per%20log%20unit%20change%20in%20gal-3%3B%2095%25%20CI%3A%207.2%2C%2065.5%2C%20p%3D0.015%29.%20The%20association%20was%20attenuated%20after%20adjusting%20for%20additional%20cardiovascular%20risk%20factors%20%28%5Cu03b2%3D17.3%2C%2095%25%20CI%3A%20-14.4%2C%2049.0%29.%20Conclusions%3A%20In%20community-dwelling%20older%20adults%2C%20gal-3%20concentration%20was%20associated%20with%20central%20arterial%20stiffness%2C%20likely%20sharing%20common%20pathways%20with%20traditional%20cardiovascular%20risk%20factors.%22%2C%22date%22%3A%22Nov%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1024%5C%2F0301-1526%5C%2Fa000968%22%2C%22ISSN%22%3A%220301-1526%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SIH54GGA%22%2C%2286PR9WQF%22%5D%2C%22dateModified%22%3A%222022-06-17T18%3A19%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22R8KIRBW7%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kobayashi%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKobayashi%2C%20M.%2C%20Kwak%2C%20M.%20J.%2C%20%26lt%3Bstrong%26gt%3BAguilar%26lt%3B%5C%2Fstrong%26gt%3B%2C%20D.%20et%20al.%20%282021%29.%20Prescribing%20trend%20of%20inappropriate%20medications%20in%20outpatient%20clinics%20for%20older%20adults%20with%20heart%20failure%20in%20the%20United%20States%3A%20NAMCS%202012%20to%202016.%20%26lt%3Bi%26gt%3BAm%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B152%26lt%3B%5C%2Fi%26gt%3B%2C%20168.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2021.04.002%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.amjcard.2021.04.002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prescribing%20trend%20of%20inappropriate%20medications%20in%20outpatient%20clinics%20for%20older%20adults%20with%20heart%20failure%20in%20the%20United%20States%3A%20NAMCS%202012%20to%202016%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masaki%22%2C%22lastName%22%3A%22Kobayashi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%20Ji%22%2C%22lastName%22%3A%22Kwak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parag%22%2C%22lastName%22%3A%22Goyal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Holly%20M.%22%2C%22lastName%22%3A%22Holmes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ashish%20A.%22%2C%22lastName%22%3A%22Deshmukh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajender%20R.%22%2C%22lastName%22%3A%22Aparasu%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Aug%201%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.amjcard.2021.04.002%22%2C%22ISSN%22%3A%221879-1913%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2286PR9WQF%22%5D%2C%22dateModified%22%3A%222021-09-27T20%3A04%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22QFB5QJ2V%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nolan%20et%20al.%22%2C%22parsedDate%22%3A%222021-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BNolan%2C%20M.%20S.%2C%20%26lt%3Bstrong%26gt%3BAguilar%26lt%3B%5C%2Fstrong%26gt%3B%2C%20D.%2C%20Misra%2C%20A.%20et%20al.%20%282021%29.%20Trypanosoma%20cruzi%20in%20nonischemic%20cardiomyopathy%20patients%2C%20Houston%2C%20Texas%2C%20USA.%20%26lt%3Bi%26gt%3BEmerg%20Infect%20Dis%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%2C%201958%26%23x2013%3B1960.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2707.203244%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2707.203244%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Trypanosoma%20cruzi%20in%20nonischemic%20cardiomyopathy%20patients%2C%20Houston%2C%20Texas%2C%20USA%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20S.%22%2C%22lastName%22%3A%22Nolan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arunima%22%2C%22lastName%22%3A%22Misra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20M.%22%2C%22lastName%22%3A%22Gunter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tim%22%2C%22lastName%22%3A%22Erickson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodion%22%2C%22lastName%22%3A%22Gorchakov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hilda%22%2C%22lastName%22%3A%22Rivera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%20P.%22%2C%22lastName%22%3A%22Montgomery%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristy%20O.%22%2C%22lastName%22%3A%22Murray%22%7D%5D%2C%22abstractNote%22%3A%22To%20investigate%20possible%20cardiac%20manifestations%20of%20Chagas%20disease%2C%20we%20tested%2097%20Latinx%20patients%20with%20nonischemic%20cardiomyopathy%20in%20Houston%2C%20Texas%2C%20USA%2C%20for%20Trypanosoma%20cruzi%20infection.%20We%20noted%20a%20high%20prevalence%20of%20underdiagnosed%20infection%20and%20discrepant%20results%20in%20clinical%20diagnostic%20assays.%20Latinx%20cardiac%20patients%20in%20the%20United%20States%20would%20benefit%20from%20laboratory%20screening%20for%20T.%20cruzi%20infection.%22%2C%22date%22%3A%22July%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3201%5C%2Feid2707.203244%22%2C%22ISSN%22%3A%221080-6059%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2286PR9WQF%22%5D%2C%22dateModified%22%3A%222021-07-20T19%3A11%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22W9HWNB6A%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hussain%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHussain%2C%20A.%2C%20Sun%2C%20W.%2C%20Deswal%2C%20A.%20et%20al.%20%282021%29.%20Association%20of%20NT-ProBNP%2C%20blood%20pressure%2C%20and%20cardiovascular%20events%3A%20The%20ARIC%20study.%20%26lt%3Bi%26gt%3BJ%20Am%20Coll%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B77%26lt%3B%5C%2Fi%26gt%3B%2C%20559%26%23x2013%3B571.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2020.11.063%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2020.11.063%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20NT-ProBNP%2C%20blood%20pressure%2C%20and%20cardiovascular%20events%3A%20The%20ARIC%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aliza%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wensheng%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Deswal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A.%22%2C%22lastName%22%3A%22de%20Lemos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22McEvoy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ron%20C.%22%2C%22lastName%22%3A%22Hoogeveen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kunihiro%22%2C%22lastName%22%3A%22Matsushita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Aguilar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biykem%22%2C%22lastName%22%3A%22Bozkurt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salim%20S.%22%2C%22lastName%22%3A%22Virani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amil%20M.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Selvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiadi%22%2C%22lastName%22%3A%22Ndumule%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christie%20M.%22%2C%22lastName%22%3A%22Ballantyne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Nambi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Although%20intensive%20blood%20pressure%20reduction%20has%20cardiovascular%20benefits%2C%20the%20absolute%20benefit%20is%20greater%20in%20those%20at%20higher%20cardiovascular%20disease%20%28CVD%29%20risk.%5CnOBJECTIVES%3A%20This%20study%20examined%20whether%20N-terminal%20pro-B-type%20natriuretic%20peptide%20%28NT-proBNP%29%20helps%20identify%20subjects%20at%20higher%20risk%20for%20CVD%20events%20across%20systolic%20blood%20pressure%20%28SBP%29%2C%20diastolic%20blood%20pressure%20%28DBP%29%2C%20or%20pulse%20pressure%20%28PP%29%20categories.%5CnMETHODS%3A%20Participants%20from%20the%20ARIC%20%28Atherosclerosis%20Risk%20In%20Communities%29%20study%20visit%204%20%281996%20to%2098%29%20were%20grouped%20according%20to%20SBP%2C%20DBP%2C%20or%20PP%20categories%20and%20further%20stratified%20by%20NT-proBNP%20categories.%20Cox%20regression%20models%20were%20used%20to%20estimate%20hazard%20ratios%20for%20incident%20CVD%20%28coronary%20heart%20disease%2C%20ischemic%20stroke%2C%20or%20heart%20failure%20hospitalization%29%20and%20mortality%20across%20combined%20NT-proBNP%20and%5C%2For%20BP%20categories%2C%20adjusting%20for%20CVD%20risk%20factors.%5CnRESULTS%3A%20There%20were%209%2C309%20participants%20%28age%3A%2062.6%20%5Cu00b1%205.6%20years%3B%2058.3%25%20women%29%20with%202%2C416%20CVD%20events%20over%20a%20median%20follow-up%20of%2016.7%20years.%20Within%20each%20SBP%2C%20DBP%2C%20or%20PP%20category%2C%20a%20higher%20category%20of%20NT-proBNP%20%28100%20to%5Cu00a0%26lt%3B300%20or%20300%20pg%5C%2Fml%2C%20compared%20with%20NT-proBNP%5Cu00a0%26lt%3B100%20pg%5C%2Fml%29%20was%20associated%20with%20a%20graded%20increased%20risk%20for%20CVD%20events%20and%20mortality.%20Participants%20with%20SBP%20130%20to%20139%5Cu00a0mm%5Cu00a0Hg%20but%20NT-proBNP%5Cu00a0%5Cu2265300%20pg%5C%2Fml%20had%20a%20hazards%20ratio%20of%203.4%20for%20CVD%20%2895%25%20confidence%20interval%3A%202.44%20to%204.77%29%20compared%20with%20a%20NT-proBNP%20of%5Cu00a0%26lt%3B100%20pg%5C%2Fml%20and%20SBP%20of%20140%20to%20149%5Cu00a0mm%5Cu00a0Hg.%5CnCONCLUSIONS%3A%20Elevated%20NT-proBNP%20is%20independently%20associated%20with%20CVD%20and%20mortality%20across%20SBP%2C%20DBP%2C%20and%20PP%20categories%20and%20helps%20identify%20subjects%20at%20the%20highest%20risk.%20Participants%20with%20stage%201%20hypertension%20but%20elevated%20NT-proBNP%20had%20greater%20cardiovascular%20risk%20compared%20with%20those%20with%20stage%202%20SBP%20but%20lower%20NT-proBNP.%20Future%20studies%20are%20needed%5Cu00a0to%5Cu00a0evaluate%20use%20of%20biomarker-based%20strategies%20for%20CVD%20risk%20assessment%20to%20assist%20with%20initiation%20or%20intensification%5Cu00a0of%5Cu00a0BP%5Cu00a0treatment.%22%2C%22date%22%3A%22Feb%209%2C%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacc.2020.11.063%22%2C%22ISSN%22%3A%221558-3597%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SIH54GGA%22%2C%2286PR9WQF%22%2C%22GL8QP2FN%22%5D%2C%22dateModified%22%3A%222023-01-12T21%3A56%3A51Z%22%7D%7D%5D%7D
Diaz, P., Coughlin, W., Lam, W. et al. (2022). Describing characteristics of adults with and without congenital heart defects hospitalized with COVID-19. Birth Defects Res. https://doi.org/10.1002/bdr2.2052.
Weiss, M. C., Shih, Y.-H., Bryan, M. S. et al. (2022). Relationships between urinary metals and diabetes traits among Mexican Americans in Starr County, Texas, USA. Biol Trace Elem Res. https://doi.org/10.1007/s12011-022-03165-y.
Kwak, M. J., Chang, M., Chiadika, S. et al. (2022). Healthcare expenditure associated with polypharmacy in older adults with cardiovascular diseases. Am J Cardiol, S0002-9149(22)00030–3. https://doi.org/10.1016/j.amjcard.2022.01.012.
Hasbani, N. R., Ligthart, S., Brown, M. R. et al. (2022). American Heart Association’s Life’s Simple 7: Lifestyle recommendations, polygenic risk, and lifetime risk of coronary heart disease. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.121.053730.
Joseph, J. J., Deedwania, P., Acharya, T. et al. (2022). Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: A scientific statement from the American Heart Association. Circulation, CIR0000000000001040. https://doi.org/10.1161/CIR.0000000000001040.
Brady, V., Whisenant, M., Wang, X. et al. (2022). Characterization of symptoms and symptom clusters for type 2 diabetes using a large nationwide electronic health record database. Diabetes Spectr 35, 159–170. https://doi.org/10.2337/ds21-0064.
Jia, X., Sun, C., Tanaka, H. et al. (2021). Association between circulating Galectin-3 and arterial stiffness in older adults. Vasa 50, 439–445. https://doi.org/10.1024/0301-1526/a000968.
Kobayashi, M., Kwak, M. J., Aguilar, D. et al. (2021). Prescribing trend of inappropriate medications in outpatient clinics for older adults with heart failure in the United States: NAMCS 2012 to 2016. Am J Cardiol 152, 168. https://doi.org/10.1016/j.amjcard.2021.04.002.
Nolan, M. S., Aguilar, D., Misra, A. et al. (2021). Trypanosoma cruzi in nonischemic cardiomyopathy patients, Houston, Texas, USA. Emerg Infect Dis 27, 1958–1960. https://doi.org/10.3201/eid2707.203244.
Hussain, A., Sun, W., Deswal, A. et al. (2021). Association of NT-ProBNP, blood pressure, and cardiovascular events: The ARIC study. J Am Coll Cardiol 77, 559–571. https://doi.org/10.1016/j.jacc.2020.11.063.